Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuromodulation and Cognitive Training for Substance Use Disorders

NCT04426214 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT04426214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04426214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuromodulation and Cognitive Training for Substance Use Disorders
Lead sponsor
University of Minnesota
Phase
Not applicable
Overall status
Terminated
Start date
July 16, 2021
Completion date
June 20, 2026
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, stimulant use